View in EDS

Validation of a commercially available SARS-CoV-2 serological immunoassay.

Saved in:
Bibliographic Details
Title: Validation of a commercially available SARS-CoV-2 serological immunoassay.
Authors: Meyer, B.1 (AUTHOR), Torriani, G.1,2 (AUTHOR), Yerly, S.3 (AUTHOR), Mazza, L.3 (AUTHOR), Calame, A.4 (AUTHOR), Arm-Vernez, I.3 (AUTHOR), Zimmer, G.5,6 (AUTHOR), Agoritsas, T.7,8 (AUTHOR), Stirnemann, J.7 (AUTHOR), Spechbach, H.9 (AUTHOR), Guessous, I.9 (AUTHOR), Stringhini, S.9,10 (AUTHOR), Pugin, J.11 (AUTHOR), Roux-Lombard, P.12 (AUTHOR), Fontao, L.13 (AUTHOR), Siegrist, C.-A.1 (AUTHOR), Eckerle, I.2,4,14 (AUTHOR), Vuilleumier, N.1,12,15 (AUTHOR), Kaiser, L.1,3,4,14 (AUTHOR) Laurent.Kaiser@hcuge.ch
Source: Clinical Microbiology & Infection. Oct2020, Vol. 26 Issue 10, p1386-1394. 9p.
Database: Environment Complete
Description
ISSN:1198743X
DOI:10.1016/j.cmi.2020.06.024